المؤلفون: van Ee TJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen 6525 GA, The Netherlands. Thomas.vanEe@radboudumc.nl., Van Acker HH; Laboratory of Experimental Hematology, University of Antwerp, Antwerp 2000, Belgium. Heleen.VanAcker@uantwerpen.be., van Oorschot TG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen 6525 GA, The Netherlands. Tom.vanOorschot@radboudumc.nl., Van Tendeloo VF; Laboratory of Experimental Hematology, University of Antwerp, Antwerp 2000, Belgium. viggovantendeloo@gmail.com., Smits EL; Laboratory of Experimental Hematology, University of Antwerp, Antwerp 2000, Belgium. Evelien.Smits@uza.be.; Center for Oncological Research, University of Antwerp, Antwerp 2000, Belgium. Evelien.Smits@uza.be., Bakdash G; Allergic Inflammation Discovery Performance Unit, Respiratory Therapy Area, GlaxoSmithKline, Stevenage SG1 2NY, UK. ghaith.x.bakdash@gsk.com., Schreibelt G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen 6525 GA, The Netherlands. gerty.schreibelt@radboudumc.nl., de Vries IJM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen 6525 GA, The Netherlands. Jolanda.devries@radboudumc.nl.; Department of Medical Oncology; Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen 6525 GA, The Netherlands. Jolanda.devries@radboudumc.nl.

المصدر: Vaccines [Vaccines (Basel)] 2018 Sep 19; Vol. 6 (3). Date of Electronic Publication: 2018 Sep 19.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Boudewijns S; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., Bol KF; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., Schreibelt G; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., Westdorp H; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., Textor JC; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., van Rossum MM; Department of Dermatology, Radboud University Medical Center , Nijmegen, the Netherlands., Scharenborg NM; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., de Boer AJ; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., van de Rakt MW; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., Pots JM; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., van Oorschot TG; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., Duiveman-de Boer T; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., Olde Nordkamp MA; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., van Meeteren WS; Department of Dermatology, Radboud University Medical Center , Nijmegen, the Netherlands., van der Graaf WT; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands; The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom., Bonenkamp JJ; Department of Surgical Oncology, Radboud University Medical Center , Nijmegen, the Netherlands., de Wilt JH; Department of Surgical Oncology, Radboud University Medical Center , Nijmegen, the Netherlands., Aarntzen EH; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands., Punt CJ; Department of Medical Oncology, Academic Medical Center , Amsterdam, the Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center Nijmegen , Nijmegen, the Netherlands., Figdor CG; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands., de Vries IJ; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.

المصدر: Oncoimmunology [Oncoimmunology] 2016 May 31; Vol. 5 (7), pp. e1191732. Date of Electronic Publication: 2016 May 31 (Print Publication: 2016).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE

المؤلفون: Schreibelt G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Bol KF; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Westdorp H; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Wimmers F; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Aarntzen EH; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Duiveman-de Boer T; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., van de Rakt MW; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Scharenborg NM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., de Boer AJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Pots JM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Olde Nordkamp MA; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., van Oorschot TG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Tel J; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Winkels G; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany., Petry K; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany., Blokx WA; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., van Rossum MM; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Welzen ME; Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands., Mus RD; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Croockewit SA; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., Koornstra RH; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Jacobs JF; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands., Kelderman S; Department of Immunology, Netherlands Cancer Institute NKI-AVL, Amsterdam, the Netherlands., Blank CU; Department of Immunology, Netherlands Cancer Institute NKI-AVL, Amsterdam, the Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Punt CJ; Department of Medical Oncology, Academic Medical Center, Amsterdam, the Netherlands., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., de Vries IJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. jolanda.devries@radboudumc.nl.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 May 01; Vol. 22 (9), pp. 2155-66. Date of Electronic Publication: 2015 Dec 28.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines/*immunology , Dendritic Cells/*immunology , Melanoma/*immunology , Melanoma/*therapy , Monocytes/*immunology , Neoplasm Metastasis/*immunology, Adult ; Aged ; Antigens, Neoplasm/immunology ; CD8-Positive T-Lymphocytes/immunology ; Chemokine CCL4/immunology ; Disease-Free Survival ; Female ; Humans ; Interferon-gamma/immunology ; Lysosomal-Associated Membrane Protein 1/immunology ; Male ; Middle Aged ; Tumor Necrosis Factor-alpha/immunology ; Vaccination/methods

المؤلفون: Bol KF; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Aarntzen EH; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., Pots JM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Olde Nordkamp MA; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., van de Rakt MW; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Scharenborg NM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., de Boer AJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., van Oorschot TG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Croockewit SA; Department of Hematology, Radboud University Medical Centre, Nijmegen, The Netherlands., Blokx WA; Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands., Oyen WJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., Boerman OC; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., Mus RD; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., van Rossum MM; Department of Dermatology, Radboud University Medical Centre, Nijmegen, The Netherlands., van der Graaf CA; Department of Pulmonary Diseases, Radboud University Medical Centre, Nijmegen, The Netherlands., Punt CJ; Department of Medical Oncology, Academic Medical Centre, Amsterdam, The Netherlands., Adema GJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., de Vries IJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Schreibelt G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. Gerty.Schreibelt@radboudumc.nl.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2016 Mar; Vol. 65 (3), pp. 327-39. Date of Electronic Publication: 2016 Feb 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines/*immunology , Dendritic Cells/*immunology , Melanoma/*therapy , Monocytes/*cytology, Adult ; Aged ; BCG Vaccine/immunology ; Cancer Vaccines/adverse effects ; Dinoprostone/pharmacology ; Female ; Hemocyanins/immunology ; Humans ; Male ; Melanoma/immunology ; Middle Aged ; Monophenol Monooxygenase/genetics ; Monophenol Monooxygenase/immunology ; T-Lymphocytes/immunology ; Vaccination ; gp100 Melanoma Antigen/genetics ; gp100 Melanoma Antigen/immunology

المؤلفون: Bol KF; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands ; Medical Oncology; Radboud university medical centre ; Nijmegen, The Netherlands., Figdor CG; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., Aarntzen EH; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands ; Radiology and Nuclear Medicine; Radboud university medical centre ; Nijmegen, The Netherlands., Welzen ME; Pharmacy; Radboud university medical centre ; Nijmegen, The Netherlands., van Rossum MM; Dermatology; Radboud university medical centre ; Nijmegen, The Netherlands., Blokx WA; Pathology; Radboud university medical centre ; Nijmegen, The Netherlands., van de Rakt MW; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., Scharenborg NM; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., de Boer AJ; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., Pots JM; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., Olde Nordkamp MA; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., van Oorschot TG; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., Mus RD; Radiology and Nuclear Medicine; Radboud university medical centre ; Nijmegen, The Netherlands., Croockewit SA; Hematology; Radboud university medical centre ; Nijmegen, The Netherlands., Jacobs JF; Laboratory Medicine; Radboud university medical centre ; Nijmegen, The Netherlands., Schuler G; Department of Dermatology; University Hospital Erlangen ; Erlangen, Germany., Neyns B; Department of Medical Oncology; Vrije Universiteit Brussel ; Brussels, Belgium., Austyn JM; Nuffield Department of Surgical Sciences; John Radcliffe Hospital; University of Oxford ; Oxford, UK., Punt CJ; Department of Medical Oncology; Academic Medical Center ; Amsterdam, The Netherlands., Schreibelt G; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands., de Vries IJ; Department of Tumor Immunology (Radboud Institute for Molecular Life Sciences); Radboud university medical centre ; Nijmegen, The Netherlands ; Medical Oncology; Radboud university medical centre ; Nijmegen, The Netherlands.

المصدر: Oncoimmunology [Oncoimmunology] 2015 Apr 01; Vol. 4 (8), pp. e1019197. Date of Electronic Publication: 2015 Apr 01 (Print Publication: 2015).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE